SCHEMBL19859914

SCHEMBL19859914

NCc1ccc(C(O)C(=O)c2ccccc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 4/20 0.67
CES1 P23141 3/20 0.67
LMNA P02545 3/20 0.67
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
MDM2 Q00987 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LOXL2 Q9Y4K0 2/20 0.43
TAAR1 Q96RJ0 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
BACE1 P56817 2/20 0.42
BACE2 Q9Y5Z0 1/20 0.42
ALKBH5 Q6P6C2 1/20 0.41
HDAC3 O15379 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19859915 0.93 LMNA (0.67) CES2CES1LMNAKDM4EALDH1A1
SCHEMBL28291616 0.91 CES2 (0.53) CES2CES1LMNAKDM4EALDH1A1
SCHEMBL5821225 0.84 LMNA (0.69) CES2CES1LMNAKDM4EALDH1A1
SCHEMBL27608906 0.83 CES2 (0.46) CES2CES1LMNAKDM4EALDH1A1
SCHEMBL18096455 0.83 CES2 (0.67) CES2CES1LMNAKDM4EALDH1A1
SCHEMBL6838582 0.83 LMNA (0.67) CES2CES1LMNAKDM4EALDH1A1
Benzoin SCHEMBL901258 0.81 CES2 (1.00) CES2CES1LMNAKDM4EALDH1A1
Benzoin SCHEMBL10665271 0.81 CES2 (1.00) CES2CES1LMNAKDM4EALDH1A1
Benzoin SCHEMBL145 0.81 CES2 (1.00) CES2CES1LMNAKDM4EALDH1A1
Benzoin SCHEMBL5833429 0.81 CES2 (1.00) CES2CES1LMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3497108-A1 CHELATED PSMA INHIBITORS Cancer Targeted Technology LLC (US) 2019-06-19 EP disclosed
WO-2018031809-A1 CHELATED PSMA INHIBITORS CANCER TARGETED TECHNOLOGY LLC (US) 2018-02-15 WO disclosed